An antibody–cytotoxic conjugate, BIIB015, is a new targeted therapy for Cripto positive tumours

Authors

Keywords

Journal

Volume 47, Issue 11, Pages 1736-1746

Publisher

Elsevier BV

Online

2011-04-15

DOI

10.1016/j.ejca.2011.02.023

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now